Clinical trials
Recruiting Phase 1/2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
891 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 8 |
| 2020 | 14 |
| 2021 | 32 |
| 2022 | 59 |
| 2023 | 124 |
| 2024 | 192 |
| 2025 | 274 |
| 2026 | 182 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 891 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Biotech | 28 |
| Chinese PLA General Hospital | 20 |
| Essen Biotech | 17 |
| AstraZeneca | 15 |
| Jiangsu HengRui Medicine Co., Ltd. | 14 |
| Fudan University | 13 |
| Institute of Hematology & Blood Diseases Hospital, China | 13 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 12 |
| Merck Sharp & Dohme LLC | 11 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 11 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 58 |
| Recurrence | 41 |
| Breast Neoplasms | 38 |
| Neoplasms | 31 |
| Multiple Myeloma | 30 |
| Pancreatic Neoplasms | 28 |
| Colorectal Neoplasms | 26 |
| Ovarian Neoplasms | 24 |
| Small Cell Lung Carcinoma | 22 |
| Leukemia, Myeloid, Acute | 20 |
Trials
Showing 1 to 25 of 891. Each trial links to its page on Pharma Observatory.
791 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.